| Literature DB >> 34072092 |
Dóra Lakk-Bogáth1, Natalija Pantalon Juraj2, Bashdar I Meena1, Berislav Perić2, Srećko I Kirin2, József Kaizer1.
Abstract
Heme and nonEntities:
Keywords: flavone synthase; iron(IV)-oxo; kinetic studies; manganese(IV)-oxo; oxidation
Mesh:
Substances:
Year: 2021 PMID: 34072092 PMCID: PMC8198008 DOI: 10.3390/molecules26113220
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Scheme 1Oxidation of flavanone by heme and nonheme flavone synthases, FS I and FS II.
Scheme 2Oxoiron(IV) and oxomanganese(IV) complexes with their iron(II) and manganese(II) precursor complexes were used in this study.
Figure 1X-ray structure of FeII(±CDA-BQA*)](CF3SO3)2 (5), showing a 30% probability of thermal ellipsoids.
Figure 2Overlay of structures FeII(CDA-BQA*)](CF3SO3)2 (5) (red) and [FeII(CDA-BPA*)](ClO4)2 (6) (blue) containing only (R,R)-enantiomers of the ligands.
Selected bond lengths of complex [FeII(±CDA-BQA*)](CF3SO3)2 (5) compared to the literature example of [FeII(CDA-BPA*)](ClO4)2 (6) complex. The geometry was determined using the program FindGeo [53].
| Fe-N1/Å | Fe-N2/Å | Fe-N3/Å | Geometry/RMSD/Å | |
|---|---|---|---|---|
| [FeII(±CDA-BQA*)](CF3SO3)2 ( | 2.194 | 2.238 | 2.252 | Pentagonal bipyramid with a vacancy (equatorial) (regular) |
| [FeII(CDA-BPA*)](ClO4)2 ( | 1.993 | 2.012 | 1.994 | Octahedron (regular) |
Catalytic oxidation of flavanone (FH2) carried out by 2, 3, 4, 5 and 6 with mCPBA in CH3CN at 25 °C.
| MII | [H2O] | [MII] | [FH2] | [ | Yield (F) | TON | Yield (D) c | TON | Yieldt |
|---|---|---|---|---|---|---|---|---|---|
| [FeII(CDA-BPA*)]2+ | 44 | 5 | 100 | 500 | 35.2 | 7.04 | 1.15 | 0.23 | 36.35 |
| [FeII(Bn-TPEN)]2+ | 44 | 5 | 100 | 500 | 29 | 5.8 | 1.4 | 0.28 | 30.4 |
| [FeII(CDA-BQA*)]2+ | 44 | 5 | 100 | 500 | 20.8 | 4.16 | 0.83 | 0.17 | 21.63 |
| [MnII(N4Py*)]2+ | 44 | 5 | 100 | 500 | 17.9 | 3.58 | 0.92 | 0.19 | 18.8 |
| [MnII(N4Py*)]2+ | 55 | 5 | 100 | 500 | 15.7 | 3.14 | 1.2 | 0.23 | 16.9 |
| [MnII(N4Py*)]2+ | 65 | 5 | 100 | 500 | 13.8 | 2.76 | 1.45 | 0.3 | 15.25 |
| [MnII(N4Py*)]2+ | 75 | 5 | 100 | 500 | 12.2 | 2.44 | 2.4 | 0.48 | 14.64 |
| [MnII(N4Py*)]2+ | 85 | 5 | 100 | 500 | 10.7 | 2.14 | 3.2 | 0.64 | 13.9 |
| [MnII(N4Py*)]2+ | 95 | 5 | 100 | 500 | 9 | 1.88 | 4.2 | 0.92 | 13.2 |
| [MnII(N4Py*)]2+ | 44 | 5 | 100 a | 500 | 16.8 a | 3.36 | 1.1 | 0.2 | 17.9 |
| [MnII(N4Py*)]2+ | 44 | 5 | 100 b | 500 | 11.2 b | 2.24 | 1.8 | 0.36 | 12.95 |
| [MnII(Bn-TPEN)]2+ | 44 | 5 | 100 | 500 | 23.1 | 4.62 | 0.61 | 0.12 | 23.7 |
a In the presence of 2,6-di-tert-butylphenol (2,6-DTBP), [2,6-DTBP] = 25 mM. b In the presence of 2,6-di-tert-butylphenol (2,6-DTBP), [2,6-DTBP] = 60 mM.c Yield of A is less than 0.1%.
Figure 3Comparison of the flavones-synthase activity of iron(II) and manganese(II) complexes. Conditions: [MII] = 5 mM, [FH2] = 100 mM and [mCPBA] = 500 mM in CH3CN at 25 °C.
Figure 4(A) Comparison of the product formation in the [MnII(N4Py*)(CH3CN)]2+ (2) catalysed oxidation of flavanone with mCPBA as co-oxidant and 2,6-DTBP as a radical trapping agent. (B) Comparison of the product formation in the presence of added water.
Figure 5Dependence of the K/A ratio and the enantiomeric excess (ee%) on the oxidant concentration for the [FeII(CDA-BPA*)]2+ (6) catalysed oxidation of ethylbenzene with TBHP in CH3CN at 0 °C.
Catalytic oxidation of ethylbenzene carried out by (R,R)-(−)-6 and (R,R)-(−)-5 with various co-oxidants a.
| [ | TON (A) b | TON (K) c | Yield | K/A | |
|---|---|---|---|---|---|
| 2:500:50 (TBHP) | 1.38 | 2.83 | 16.84 | 2.05 | 7.25 (R) |
| 2:500:100 (TBHP) | 1.82 | 5.20 | 14.04 | 2.86 | 4.13 (R) |
| 2:500:200 (TBHP) | 2.06 | 6.17 | 8.23 | 3.00 | 2.68 (R) |
| 2:1500:16 (PhIO) | 0.96 | 2.14 | 38.75 | 2.23 | 12.21 (R) |
| [ | TON (A b) | TON (K c) | Yield | K/A | |
| 2:500:100 (TBHP) | - | 10.08 | 20.16 | - | - |
a Reaction conditions: see Experimental section. b 1-Phenylethanol. c Acetophenone. d Based on oxidant.
Rate constants and activation parameters for the oxidation of flavanone with oxometal(IV) complexes.
| Complex | 103 | Δ | Δ | Δ | Solvent | Refs. |
|---|---|---|---|---|---|---|
| [FeIV(O)(N4Py*)]2+ ( | 0.24 ± 0.01 | 70 ± 3 | −75 ± 9 | 92.2 | CH3CN (25 °C) | [ |
| [FeIV(O)(N4Py)]2+ | 0.57 ± 0.03 | 63 ± 4 | −93 ± 13 | 90.9 | CH3CN (25 °C) | [ |
| [FeIV(O)(N2Py2Q*)]2+ | 19.2 ± 1.1 | 48 ± 2 | −121 ± 8 | 83.7 | CH3CN (25 °C) | [ |
| [FeIV(O)(N2Py2Q*)]2+ | 6.50 ± 0.32 | CH3CN (10 °C) | [ | |||
| [FeIV(O)(Bn-TPEN)]2+ ( | 1340 ± 67 | 28 ± 2 | −150 ± 8 | 72.7 | CH3CN (25 °C) | This work |
| [FeIV(O)(Bn-TPEN)]2+ ( | 680 ± 27 | CH3CN (10 °C) | This work | |||
| [FeIV(O)(Bn-TPEN)]2+ ( | 1520 ± 90 | CH3CN/TFE (10 °C) | This work | |||
| [FeIV(O)(CDA-BPA*)]2+ ( | 970 ± 40 | CH3CN (10 °C) | This work | |||
| [MnIV(O)(N4Py*)]2+ ( | 0.58 ± 0.03 | CH3CN/TFE (25 °C) | This work | |||
| [MnIV(O)(Bn-TPEN)]2+ ( | 420 ± 15 | 43 ± 3 | −114 ± 10 | 76.7 | CH3CN/TFE (10 °C) | This work |
Figure 6(A) UV-Vis spectral changes of 9 (2 mM, red line) upon addition of flavanone (50 mM) in CH3CN at 10 °C. The inset shows the time course of the decay of 9 monitored at 739 nm. (B) UV-Vis spectral changes of 11 (2 mM, red line) upon addition of flavanone (50 mM) in CH3CN at 10 °C. The inset shows the time course of the decay of 11 monitored at 742 nm.
Figure 7(A) Determination and comparison of second-order rate constants by plotting kobs values against flavanone concentration for a series of MIV(O) complexes in CH3CN at 10 °C, [M]0 = 2 mM. (B) Eyring plots of log k/T versus 1/T for 9 and 10, [9,10] = 2 mM, [FH2] = 50 mM.
Figure 8(A) Isokinetic plot and (B) plot of ΔG‡ versus lnk2 for the oxidation of flavanone with various oxomanganese(IV) and oxoiron(IV) complexes.
Figure 9(A) UV-Vis spectral changes of 8 (2 mM, red line) upon addition of flavanone (1.8 M) in CH3CN/TFE at 25 °C. The inset shows the time nd course of the decay of 8 monitored at 944 nm. (B) Determination and comparison of second-order rate constants by plotting kobs values against flavanone concentration for complexes 7 and 8 in CH3CN and CH3CN/TFE at 25 °C, [M]0 = 2 mM.
Scheme 3Proposed mechanism for the C-H activation by oxoiron and oxomanganese complexes.